Archives: Articles
Approaches for Use of Digital Health Technologies in Clinical Trials
FDA CDER is inviting qualified pharma companies to participate in the next round of Quality Management Maturity (QMM) protocol assessment.
In Regulatory Focus: The FDA’s Quality Management by Robert Michalik, JD, RAC, and William Hauck, MSc
24-7_Michalik et al
Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs
QMM for Pharmaceutical Manufacturers– Implications for Drug Manufacturers, API Suppliers and Contract Manufacturers
Pharmaceutical QMM Model: QMM Assessment to Promote Pharmaceutical Operational Excellence
